VEEV
Veeva Systems Inc
$310.1-0.17%
Setup
No setup
Buy Zone
$299.04-$313.99
Sector
Health Information Services
Industry
Health Information Services
56
Recommendation
Avoid
Avoid
Too many CANSLIM criteria failing.
VEEV chart
Loading chart…
ADX
Developing25.8Long Term
Range →Intermediate Term
Range →Short Term
Up ↑Overall Quality56
RS Rating
42
relative strength
Fundamentals
77
Strong fund-Q
Volume Demand
68
+29% vs avg
Technical Setup
63
5/8 checks
Industry/Theme
91
Health Information Services
Trade Plan
Avoid
Entry
$299.04
Entry Zone
$299.04-$313.99
Stop / Risk
$275.12
RS Rating
42
Volume confirmed
No
Targets
$358.85 / $373.8
Breakout · IBD Setup
4 ✓ 4 ✗
Entry $299.04–$313.99Stop $275.12Target $358.85 / $373.8
Market regimeRange
Quality56
RS Rating42
Above 50-MA+7.41%
Above 200-MA+46.97%
VolumeWeak
In Buy ZoneYes
Not extendedOK
Invalidation · Close below stop
How this came together
56
MarketRange
SetupNo setup
ConfidenceExperimental · not backtested
Fund-Q77 · Strong
StatusAvoid
Stock Data
52-Week Range148 – 326
Price % Chg YTD38.92%
Price % Chg 4wk9.77%
50-Day Avg Vol1.7 Mil
P/E Ratio51.5
Market Cap$51B
SectorHealthcare
IndustryHealth Information Services
Company Fundamentals
EPS % Chg (Qtr)38.67%
Sales % Chg (Qtr)17.6%
EPS Growth 5y18.15%
Sales Growth 5y16.88%
Annual ROE14.42%
Gross Margin74.83%
Operating Margin29.93%
Net Margin29.34%
Debt / Equity0.02
Setup levels
Current price
$310.1
Pivot
$299.04
Distance to buy
-4.9%
52-week range
148.05-325.97
Trigger evidence
No active trigger evidence available.
Financial health checks
4/5
Return on equity above 15%
ROE 14.42%
Net margin above 10%
Net margin 29.34%
EPS growing quarter on quarter
EPS q/q 38.67%
Sales growing quarter on quarter
Sales q/q 17.6%
Debt to equity below 1.0
D/E 0.02
Key metrics
Finviz snapshot · value vs. sector median (≥5 peers)
Annual ROE14.42%
vs sector -8.2%
Net margin29.34%
vs sector +11.7%
Gross margin74.83%
vs sector +7.7%
EPS growth q/q38.67%
vs sector +31.1%
Sales growth q/q17.6%
vs sector -1.1%
Debt / equity0.02
vs sector -0.63
Business quality
77
GradeStrong
EPS rating63
P/E51.5
Market cap$51B
IndustryHealth Information Services
Technical checks
Über 50-MA
Pass
Über 200-MA
Pass
RS-Linie auf neuem Hoch
Fail
Volumen bestätigt
Fail
In Kaufzone
Pass
Nicht überextended
Pass
Über 21-EMA
Fail
Volumen gesund
Pass
IBD / source mentions
No recent IBD mention found for this ticker.
Signal history
Added to list
2026-10-31
Trigger date
—
Days on list
6
Data sources: internal CANSLIM engine · Finviz snapshot · TradingView chart. Not investment advice.